Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...

The sickle cell disease treatment market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical players, ...

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

Five NY research centers form Empire State Cellular Therapy Consortium to accelerate cell therapy access for patients.

Sickle cell is now the fastest growing genetic condition in the United Kingdom and can cause organ damage and strokes.

A study by the Centre for Policy Impact in Global Health revealed that over 30 per cent of people with SCD in Nigeria ...

Oregon will initially focus on providing lower-cost therapies for people living with sickle cell disease, a genetic blood ...